IMW 2019 | Highlights from IMW 2019 Part I

Francesca Gay and Katja Weisel

Katja Weisel, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, and Francesca Gay, MD, University of Turin, Turin, Italy, discuss highlights from the International Myeloma Workshop (IMW) 2019, held in Boston, MA, with particular focus on the CASSIOPEIA trial (NCT02541383) and the future of measurable residual disease (MRD) in myeloma treatment.

Share this video